Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
Greig NH, Lecca D, Hsueh SC, Nogueras-Ortiz C, Kapogiannis D, Tweedie D, Glotfelty EJ, Becker RE, Chiang YH, Hoffer BJ. Greig NH, et al. Among authors: kapogiannis d. CNS Neurosci Ther. 2020 Jun;26(6):636-649. doi: 10.1111/cns.13274. Epub 2019 Dec 11. CNS Neurosci Ther. 2020. PMID: 31828969 Free PMC article. Review.
Insulin resistance and exendin-4 treatment for multiple system atrophy.
Bassil F, Canron MH, Vital A, Bezard E, Li Y, Greig NH, Gulyani S, Kapogiannis D, Fernagut PO, Meissner WG. Bassil F, et al. Among authors: kapogiannis d. Brain. 2017 May 1;140(5):1420-1436. doi: 10.1093/brain/awx044. Brain. 2017. PMID: 28334990 Free PMC article.
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneider LS, Flanagan D, Govindarajan R, Sano M, Ferrucci L, Kapogiannis D. Becker RE, et al. Among authors: kapogiannis d. Curr Alzheimer Res. 2018;15(9):883-891. doi: 10.2174/1567205015666180110120026. Curr Alzheimer Res. 2018. PMID: 29318971 Free PMC article. Review.
Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease.
Goetzl EJ, Nogueras-Ortiz C, Mustapic M, Mullins RJ, Abner EL, Schwartz JB, Kapogiannis D. Goetzl EJ, et al. Among authors: kapogiannis d. FASEB J. 2019 Jan;33(1):231-238. doi: 10.1096/fj.201801001. Epub 2018 Jun 20. FASEB J. 2019. PMID: 29924942 Free PMC article.
., Mustapic, M., Mullins, R. J., Abner, E. L., Schwartz, J. B., Kapogiannis, D. Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease....
., Mustapic, M., Mullins, R. J., Abner, E. L., Schwartz, J. B., Kapogiannis, D. Deficient neurotrophic factors of CSPG4-type n …
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial.
Athauda D, Gulyani S, Karnati HK, Li Y, Tweedie D, Mustapic M, Chawla S, Chowdhury K, Skene SS, Greig NH, Kapogiannis D, Foltynie T. Athauda D, et al. Among authors: kapogiannis d. JAMA Neurol. 2019 Apr 1;76(4):420-429. doi: 10.1001/jamaneurol.2018.4304. JAMA Neurol. 2019. PMID: 30640362 Free PMC article. Clinical Trial.
184 results